Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
2.000
-0.150 (-6.98%)
Apr 22, 2026, 9:30 AM EST
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $55.4 million as of April 22, 2026. Its market cap has increased by 902.65% in one year.
Market Cap
55.40M
Enterprise Value
54.08M
Revenue
38.73M
Ranking
n/a
PE Ratio
2.22
Stock Price
$2.00
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 55.40M, a decrease of -75.04%. That is a compound annual growth rate of -4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 55.40M | 916.92% |
| Dec 31, 2025 | 5.45M | -54.11% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Global Cord Blood | 127.22M |
| Bioqual | 33.55M |
| Aspira Women's Health | 16.53M |
| Longduoduo Company | 15.31M |
| Psychemedics | 13.46M |
| Stella Diagnostics | 4.82M |
| Hypha Labs | 4.67M |
| Centogene | 3.58M |